BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report) was down 1.4% on Friday . The company traded as low as $1.71 and last traded at $1.71. Approximately 4,718 shares were traded during trading, a decline of 69% from the average daily volume of 15,068 shares. The stock had previously closed at $1.74.
BeyondSpring Trading Down 1.4 %
The firm has a fifty day simple moving average of $1.69 and a 200-day simple moving average of $1.96.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in BeyondSpring stock. Renaissance Technologies LLC bought a new position in BeyondSpring Inc. (NASDAQ:BYSI – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 12,500 shares of the company’s stock, valued at approximately $30,000. Institutional investors and hedge funds own 40.29% of the company’s stock.
About BeyondSpring
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Read More
- Five stocks we like better than BeyondSpring
- Stock Sentiment Analysis: How it Works
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- How to Buy Cheap Stocks Step by Step
- Bloom Energy: Powering the Future With Decentralized Energy
- What is the Euro STOXX 50 Index?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
